BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31801554)

  • 1. Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of long-term mortality in patients with coronary artery disease after undergoing percutaneous coronary intervention: a retrospective cohort study.
    Dai XY; Zheng YY; Tang JN; Yang XM; Guo QQ; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Zhang ZL; Zheng RJ; Zhang JY
    Lipids Health Dis; 2019 Dec; 18(1):210. PubMed ID: 31801554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaline phosphatase-to-albumin ratio as a novel predictor of long-term adverse outcomes in coronary artery disease patients who underwent PCI.
    Dai XY; Zheng YY; Tang JN; Wang W; Guo QQ; Yin SS; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Zhang ZL; Zheng RJ; Zhang JY
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34121126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Nutritional Index as a Novel Predictor of Long-Term Prognosis in Patients with Coronary Artery Disease After Percutaneous Coronary Intervention.
    Liu TD; Zheng YY; Tang JN; Wang W; Dai XY; Zhang JC; Guo QQ; Cheng MD; Song FH; Fan L; Liu ZY; Zhang ZL; Bai Y; Wang K; Yue XT; Zheng RJ; Zhang JY
    Clin Appl Thromb Hemost; 2022; 28():10760296221103271. PubMed ID: 36001005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate pressure product as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study.
    Jiang ZH; Aierken A; Wu TT; Zheng YY; Ma YT; Xie X
    BMJ Open; 2023 Apr; 13(4):e067951. PubMed ID: 37015792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting blood glucose to HDL-C ratio as a novel predictor of clinical outcomes in non-diabetic patients after PCI.
    Guo QQ; Zheng YY; Tang JN; Wu TT; Yang XM; Zhang ZL; Zhang JC; Yang Y; Hou XG; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Dai XY; Zheng RJ; Xie X; Zhang JY
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33140818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline white blood cell count-to-apolipoprotein A1 ratio as a novel predictor of long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a retrospective cohort study.
    Pan Y; Zhang J; Wu TT; Hou XG; Yang Y; Ma X; Ma YT; Zheng YY; Xie X
    Lipids Health Dis; 2020 Mar; 19(1):43. PubMed ID: 32178685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An elevated monocyte-to-high-density lipoprotein-cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI.
    Zhang DP; Baituola G; Wu TT; Chen Y; Hou XG; Yang Y; Pan Y; Ma X; Zheng YY
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALT-to-Lymphocyte Ratio as a Predictor of Long-Term Mortality in Patients with Normal Liver Function Presenting Coronary Artery Disease after Undergoing PCI: A Retrospective Cohort Study.
    Zheng RJ; Guo QQ; Tang JN; Yang XM; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Dai XY; Zhang ZL; Zheng YY; Zhang JY
    J Interv Cardiol; 2020; 2020():4713591. PubMed ID: 32372887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-Glutamyl Transferase-to-Platelet Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Zheng YY; Wu TT; Chen Y; Hou XG; Yang Y; Ma X; Ma YT; Zhang JY; Xie X
    Thromb Haemost; 2019 Jun; 119(6):1021-1030. PubMed ID: 30822808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
    Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
    Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White Blood Cell Counts to High-Density Lipoprotein Cholesterol Ratio, as a Novel Predictor of Long-Term Adverse Outcomes in Patients After Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Wu TT; Zheng YY; Xiu WJ; Wang WR; Xun YL; Ma YY; Kadir P; Pan Y; Ma YT; Xie X
    Front Cardiovasc Med; 2021; 8():616896. PubMed ID: 34307487
    [No Abstract]   [Full Text] [Related]  

  • 13. Relation of Low-Density Lipoprotein Cholesterol With Microvascular Injury and Clinical Outcome in Revascularized ST-Elevation Myocardial Infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Theurl M; Basic D; Eigler C; Holzknecht M; Mair J; Mayr A; Klug G; Metzler B
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention.
    Zhao ZW; Xu YW; Li SM; Guo JJ; Sun JM; Hong JC; Chen LL
    Dis Markers; 2019; 2019():4925767. PubMed ID: 31772687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Wu TT; Zheng YY; Chen Y; Yu ZX; Ma YT; Xie X
    Lipids Health Dis; 2019 Oct; 18(1):180. PubMed ID: 31640740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study.
    Ren X; Wang X
    Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-to-albumin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention.
    Zhang ZL; Guo QQ; Tang JN; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Dai XY; Zheng RJ; Zheng YY; Zhang JY
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34137842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of nonfasting triglycerides/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins.
    Matsumoto I; Misaki A; Kurozumi M; Nanba T; Takagi Y
    J Cardiol; 2018 Jan; 71(1):10-15. PubMed ID: 28916255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients.
    Sultani R; Tong DC; Peverelle M; Lee YS; Baradi A; Wilson AM
    Heart Lung Circ; 2020 Mar; 29(3):414-421. PubMed ID: 31014557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of Gensini Score in the Long-Term Outcomes of Patients With Coronary Artery Disease Who Underwent PCI.
    Wang KY; Zheng YY; Wu TT; Ma YT; Xie X
    Front Cardiovasc Med; 2021; 8():778615. PubMed ID: 35141291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.